Ascendis Pharma Europe A/S — Credit Rating and Financial Key Figures
Credit rating
Company information
About Ascendis Pharma Europe A/S
Ascendis Pharma Europe A/S (CVR number: 44420449) is a company from GENTOFTE. The company recorded a gross profit of 27 kEUR in 2024. The operating profit was -5 kEUR, while net earnings were -5 kEUR. The profitability of the company measured by Return on Assets (ROA) was -6.2 %, which can be considered poor and Return on Equity (ROE) was -10.2 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 61.3 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. Ascendis Pharma Europe A/S's liquidity measured by quick ratio was 1.7 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kEUR)
EBIT (kEUR)
Profitability
Solidity
Key figures (kEUR)
See financials2024 | |
---|---|
Volume | |
Net sales | |
Gross profit | 27.00 |
EBIT | -5.00 |
Net earnings | -5.00 |
Shareholders equity total | 49.00 |
Balance sheet total (assets) | 80.00 |
Net debt | -17.00 |
Profitability | |
EBIT-% | |
ROA | -6.3 % |
ROE | -10.2 % |
ROI | -7.1 % |
Economic value added (EVA) | -5.00 |
Solvency | |
Equity ratio | 61.3 % |
Gearing | 42.9 % |
Relative net indebtedness % | |
Liquidity | |
Quick ratio | 1.7 |
Current ratio | 1.7 |
Cash and cash equivalents | 38.00 |
Capital use efficiency | |
Trade debtors turnover (days) | |
Net working capital % | |
Credit risk | |
Credit rating | BB |
Variable visualization
Roles
Companies in the same industry
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions

... and more!
No registration needed.